Among various treatment modalities for breast cancer management—including surgery, radiation, and chemotherapy—endocrine therapy is reserved for patients diagnosed with hormone receptor (HR) (either estrogen receptor (ER) or progesterone receptor (PR)) positive breast cancer [11]. Here, NR4A1 is linked to breast carcinoma.